Literature DB >> 20544243

Acrylamine-induced autoimmune phenomena.

Bruce Rothschild1.   

Abstract

The objective of this study is to document a series of cases of occupationally derived autoimmune disease. Individuals with occupational exposure to acrylamides were evaluated clinically and biochemically/immunologically for evidence of autoimmune disease. Symptoms and signs and immuno-reactivity were monitored during exposure-free and re-exposure as part of the individuals' clinical evaluation. Six individuals with occupational acrylamide exposure had clinical and laboratory alterations characteristic of drug-induced autoimmune disease, specifically lupus, anti-phospholipid syndrome, Sjogren's syndrome, scleroderma, and polymyositis. The similarity of the full spectrum of disease in the reported patients to that found with procainamide strongly suggests the effects of occupational exposure. This uncontrolled study suggests the need for a full epidemiologic analysis of all individuals working with such occupational exposure, including full clinical and immunological examination.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20544243     DOI: 10.1007/s10067-010-1513-4

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  63 in total

1.  Adverse effects of sulfasalazine in patients with rheumatoid arthritis are associated with diplotype configuration at the N-acetyltransferase 2 gene.

Authors:  Eiichi Tanaka; Atsuo Taniguchi; Wako Urano; Hiroshi Nakajima; Yuko Matsuda; Yutaka Kitamura; Masayuki Saito; Hisashi Yamanaka; Terunobu Saito; Naoyuki Kamatani
Journal:  J Rheumatol       Date:  2002-12       Impact factor: 4.666

2.  Todralazine hepatotoxicity: a sting in the histone tail.

Authors:  Ahmed M Elsharkawy
Journal:  J Hepatol       Date:  2006-12-01       Impact factor: 25.083

3.  High-performance liquid chromatography assay of N,N-dimethyl-p-toluidine released from bone cements: evidence for toxicity.

Authors:  S Stea; D Granchi; C Zolezzi; G Ciapetti; M Visentin; D Cavedagna; A Pizzoferrato
Journal:  Biomaterials       Date:  1997-02       Impact factor: 12.479

4.  Antihistone antibodies in systemic lupus erythematosus.

Authors:  R L Rubin; S Waga
Journal:  J Rheumatol Suppl       Date:  1987-06

Review 5.  Drug-induced lupus: an update.

Authors:  S Vasoo
Journal:  Lupus       Date:  2006       Impact factor: 2.911

Review 6.  Migraine, memory loss, and "multiple sclerosis ". Neurological features of the antiphospholipid (Hughes') syndrome.

Authors:  G R V Hughes
Journal:  Postgrad Med J       Date:  2003-02       Impact factor: 2.401

7.  The relationship between arthritis and human parvovirus B19 infection.

Authors:  R Caliskan; S Masatlioglu; M Aslan; S Altun; S Saribas; S Ergin; E Uckan; V Koksal; V Oz; K Altas; I Fresko; B Kocazeybek
Journal:  Rheumatol Int       Date:  2004-08-20       Impact factor: 2.631

Review 8.  Drug-induced autoimmunity.

Authors:  Nancy J Olsen
Journal:  Best Pract Res Clin Rheumatol       Date:  2004-10       Impact factor: 4.098

9.  Simultaneous determination of 7 N-acetyltransferase-2 single-nucleotide variations by allele-specific primer extension assay.

Authors:  Yusheng Zhu; David W Hein; Mark A Doll; Kristen K Reynolds; Ntei Abudu; Roland Valdes; Mark W Linder
Journal:  Clin Chem       Date:  2006-03-23       Impact factor: 8.327

10.  Systemic autoimmune disease mortality and occupational exposures.

Authors:  L S Gold; M H Ward; M Dosemeci; A J De Roos
Journal:  Arthritis Rheum       Date:  2007-10
View more
  3 in total

Review 1.  Drug-induced lupus erythematosus: incidence, management and prevention.

Authors:  Christopher Chang; M Eric Gershwin
Journal:  Drug Saf       Date:  2011-05-01       Impact factor: 5.606

2.  Stepwise approach to myopathy in systemic disease.

Authors:  Jasvinder Chawla
Journal:  Front Neurol       Date:  2011-08-05       Impact factor: 4.003

Review 3.  Rheumatic diseases induced by drugs and environmental factors: the state-of-the-art - part two.

Authors:  Karolina Niklas; Arkadiusz A Niklas; Dominik Majewski; Mariusz J Puszczewicz
Journal:  Reumatologia       Date:  2016-10-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.